1. World Health Organization
21 November 2017
Progress Towards Global Immunization Goals
Summary presentation of key indicators
Updated July 2017

2. World Health Organization
Global and Regional Immunization coverage with DTP3, , global coverage at 86% in 2016
21 November 2017
Source: WHO/UNICEF coverage estimates 2016 revision, July 2017.
Immunization Vaccines and Biologicals, (IVB), World Health Organization.
194 WHO Member States. Date of slide: 15 July 2017.

3. Immunization coverage with DTP3 vaccines in infants (from <50%), 2016
<50% (8 countries or 4%)
50-79% (27 countries or 14%)
80-89% (29 countries or 15%)
>=90% (130 countries or 67%)
Not available
The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. © WHO All rights reserved
Source: WHO/UNICEF coverage estimates 2016 revision, July Map production: Immunization Vaccines and Biologicals, (IVB). World Health Organization. 194 WHO Member States. Date of slide: 19 July 2017
Not applicable

4. World Health Organization
Coverage with three doses of diphtheria, tetanus, and pertussis (DTP3) containing vaccines, by country income levels,
21 November 2017
96%
High-income countries
86%
78%
Global
Low-income countries
Source: WHO/UNICEF coverage estimates 2016 revision, July 2017, and Country Income Categories (World Bank), as of July 2017 (2016 GNI per capita). Income classification not available for: Cook Islands and Niue.
Immunization Vaccines and Biologicals, (IVB), World Health Organization.
194 WHO Member States. Date of slide: 17 July 2017.

5. Number of countries reached and sustained 90% coverage with 3 doses of DTP containing vaccines since and global DTP3 coverage
Source: WHO/UNICEF coverage estimates 2016 revision, July 2017.
Immunization Vaccines and Biologicals, (IVB), World Health Organization.
194 WHO Member States. Date of slide: 15 July

6. World Health Organization
19.5 million infants not immunized (DTP3), 2016
21 November 2017
Source: WHO/UNICEF coverage estimates 2016 revision, July United Nations, Population Division. The World Population Prospects revision. New York, 2017.
Immunization Vaccines and Biologicals, (IVB), World Health Organization.
194 WHO Member States. Date of slide: 17 July 2017.

7. GLOBAL Annual surviving infants cohort = 136.1 million
World Health Organization
GLOBAL Annual surviving infants cohort = million
21 November 2017
86% DTP3 coverage million children vaccinated
Source: WHO/UNICEF coverage estimates 2016 revision, July United Nations, Population Division. The World Population Prospects revision. New York, 2017.
Immunization Vaccines and Biologicals, (IVB), World Health Organization.
194 WHO Member States. Date of slide: 28 July 2017.

8. Top 10 countries with most under- and un-vaccinated children (DTP3), in 2016
Source: WHO/UNICEF coverage estimates 2016 revision, July 2017.
Immunization Vaccines and Biologicals, (IVB), World Health Organization.
194 WHO Member States. Date of slide: 15 July 2017.

9. “Developing”* countries with all districts achieving at least 80% DTP3 coverage, 2016
All districts >= 80% (42 countries or 27%)
*155 developing countries and economies in transition per UN World Economic & Social Survey, 2017 classification
Not all districts >=80% (91 countries or 59%)
No district data available (22 countries or 14%)
Developed economies (39 countries )
Not available
The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. © WHO All rights reserved
Source: WHO Database, as at 11 July Map production: Immunization Vaccines and Biologicals, (IVB). World Health Organization. 194 Member States. Date of slide: 26 July 2017
Not applicable

10. “Developing”* countries with % of districts achieving at least 80% DTP3 coverage, 2016
<50% of districts (23 countries or 15%)
*155 developing countries and economies in transition per UN World Economic & Social Survey, 2017 classification
50-79% of districts (30 countries or 19%)
80-99% of districts (38 countries or 25%)
100% of districts (42 countries or 27%)
Developed economies (39 countries )
The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. © WHO All rights reserved
Source: WHO Database, as at 11 July Map production: Immunization Vaccines and Biologicals, (IVB). World Health Organization. 194 Member States. Date of slide: 26 July 2017
Not Available (22 countries or 14%)
Not applicable

11. World Health Organization
Number of vaccines/antigens introduced in national immunization schedules compared to July 2016
21 November 2017
Selected antigens are :
Diphtheria, Tetanus, Pertussis, Measles, Polio - universal use
Hepatitis B,
Heamophilius Influenza type B,
Pneumococcal conjugate
Rotavirus
Rubella
2000
5 antigens (DTP, Measles and Polio)
6 antigens
7 antigens
8 antigens
9 antigens
≥10 antigens
The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. © WHO All rights reserved
Not applicable
2016
Not available
Source:WHO/IVB Database, as at 11 July 2017.
Map production: Immunization Vaccines and Biologicals, (IVB), World Health Organization
194 WHO Member States. Date of slide: 31 July 2017.

12. Polio Eradication Progress, 1988 – 2016
World Health Organization
Polio Eradication Progress, 1988 – 2016
21 November 2017
Certified polio-free regions (126 countries)
Endemic with wild poliovirus ( 3 countries)
Not certified but non-endemic (65 countries)
Source: WHO/POLIO database, as of Aug 2017.
194 member states.
The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. © WHO All rights reserved

13. World Health Organization
Progress in Polio Eradication,
Estimated and Reported Polio Cases,
21 November 2017
1988: WHA Resolution to Eradicate Polio
2000: Original Target Date for Interruption of Transmission Reported cases:
Estimated cases: 3 500
1999: WHA Resolution to accelerate polio eradication activities
2016: Reported wild poliovirus cases: 37
Source: WHO/POLIO database, as of Aug 2017.
194 member states.

14. Immunization coverage with 1st dose of measles containing vaccines in infants, 2016
<50% (7 countries or 4%)
50-79% (32 countries or 16%)
80-89% (32 countries or 16%)
>=90% (123 countries or 64%)
Source: WHO/UNICEF coverage estimates 2016 revision, July Map production: Immunization Vaccines and Biologicals, (IVB). World Health Organization.
194 WHO Member States. Date of slide: 19 July 2017
Not available
The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. © WHO All rights reserved
Not applicable

15. World Health Organization
ARE WE ON TRACK TO REACH OUR GVAP COVERAGE GOALS ?
Global Immunization and
projections to reach 90% global coverage goals in MCV1 coverage
21 November 2017
Source: WHO/UNICEF coverage estimates 2016 revision, July 2017
Immunization Vaccines and Biologicals, (IVB), World Health Organization.
194 WHO Member States. Date of slide: 15 July 2017

16. 41 Countries. have eliminated MNT between 2000 & 2016
41 Countries* have eliminated MNT between 2000 & *Plus Ethiopia except Somali region, 16/17 regions in Philippines, and Punjab region of Pakistan - leaving 18 countries yet to eliminate MNT
MNT eliminated from
Source: WHO/UNICEF Database.
Map production: Immunization Vaccines and Biologicals, (IVB), World Health Organization.
Date of slide: 06 July 2017.
The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement.
 WHO All rights reserved
MNT not eliminated
MNT eliminated before 2000

17. Countries providing vitamin A supplementation with routine and/or supplementary immunization activities, 2016
Vitamin A distributed with routine and supplementary immunization activities (21 countries or 29%)
Vitamin A distributed only with routine immunization services (29 countries or 40%)
Vitamin A distributed only with supplementary immunization activities (6 countries or 8%)
Source: WHO/UNICEF database as at 11 July Map production: Immunization Vaccines and Biologicals, (IVB), World Health Organization.
194 WHO Member States. Date of slide: 28 July 2017.
Not available/No Vitamin A distribution (17 countries or 23%)
Not a Countdown country (119) or Countdown country for which Vitamin A deficiency is not a public health problem (2)
The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. © WHO All rights reserved

18. World Health Organization
Number of countries having introduced Hepatitis B vaccine and global infant coverage for Hepatitis B 3rd dose (HepB3),
21 November 2017
Source: WHO/UNICEF coverage estimates 2016 revision, July 2017 , and WHO database as at 06 July Immunization Vaccines and Biologicals, (IVB), World Health Organization. 194 WHO Member States. Date of slide: 26 July 2017.
2016: excluding 3 countries where HepB administered for adolescents

19. Immunization coverage with HepB3 in infants, 2016
<50% (7 countries or 4%)
50-79% (32 countries or 16%)
80-89% (28 countries or 14%)
>=90% (118 countries or 61%)
Not available / HepB not introduced or no coverage data available (9 countries or 5%)
Source: WHO/UNICEF coverage estimates 2016 revision, July Map production: Immunization Vaccines and Biologicals, (IVB). World Health Organization WHO Member States. Date of slide: 24 July 2017.
Not applicable
The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. © WHO All rights reserved

20. World Health Organization
Countries having introduced Hib vaccine
in the last 20 years ( )
21 November 2017
1997
29 countries introduced
2 countries partially introduced
2016
190 countries introduced
1 countries partially introduced
Source: WHO/UNICEF coverage estimates 2016 revision, July WHO Member States. Map production: Immunization Vaccines and Biologicals, (IVB). World Health Organization. Date of slide: 27 July 2017.
The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement.  WHO All rights reserved

21. Immunization coverage with PCV3 in infants, 2016
<50% (11 countries or 6%)
50-79% (25 countries or 13%)
80-89% (25 countries or 13%)
>=90% (68 countries or 35%)
PCV in schedule but no coverage data available (6 countries or 3%)
Source: WHO/UNICEF coverage estimates 2016 revision, July Map production: Immunization Vaccines and Biologicals, (IVB). World Health Organization. 194 WHO Member States. Date of slide: 27 July 2017
Not available / not in national immunization schedule (59 countries or 30%)
Not applicable
The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement.  WHO All rights reserved

22. Immunization coverage with Rotavirus vaccine in infants, 2016
<50% (9 countries or 5%)
50-79% (22 countries or 11%)
80-89% (15 countries or 8%)
>=90% (38 countries or 20%)
Rotavirus vaccine in schedule but no coverage data available (7 countries or 4%)
Source: WHO/UNICEF coverage estimates 2016 revision, July Map production: Immunization Vaccines and Biologicals, (IVB). World Health Organization. 194 WHO Member States. Date of slide: 24 July 2017
Not available / not in national immunization schedule (103 countries or 53%)
Not applicable
The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement.  WHO All rights reserved

23. World Health Organization
Countries with a 3-5 year strategic plan for the national immunization system, 2016
21 November 2017
Yes (146 countries or 75%)
No (32 countries or 16%)
No data (16 countries or 8%)
Not available
The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. © WHO All rights reserved
Source: WHO/IVB Database, as at 11 July Map production: Immunization Vaccines and Biologicals (IVB), World Health Organization.
194 WHO Member States Date of slide: 28 July 2017.
Not applicable

24. World Health Organization
Countries with a national annual work plan for immunization services, 2016
21 November 2017
Yes (163 countries or 84%)
No (12 countries or 6%)
No data (19 countries or 10%)
Not available
The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. © WHO All rights reserved
Source: WHO/IVB Database, as at 11 July Map production: Immunization Vaccines and Biologicals (IVB), World Health Organization.
194 WHO Member States. Date of slide: 28 July 2017.
Not applicable

25. World Health Organization
Countries having a policy being implemented for immunization injection safety, 2016
21 November 2017
Yes (148 countries or 76%)
No (17 countries or 9%)
No data (29 countries or 15%)
Not available
The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. © WHO All rights reserved
Source: WHO/IVB Database, as at 11 July Map production: Immunization Vaccines and Biologicals (IVB), World Health Organization.
194 WHO Member States. Date of slide: 28 July 2017.
Not applicable

26. National Immunization Technical Advisory Groups (NITAGs) in 2016
83 Countries meeting the 6 NITAG criteria
122 Countries having a NITAG with administrative or legislative basis
122 Countries Reporting the Existence of A NITAG with Terms of Reference
129 Countries Reporting the Existence of a NITAG
Data source: WHO/IVB Database, as at 21 July Map production: Immunization Vaccines and Biologicals (IVB), World Health Organization.
194 WHO Member States.
Not available
The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO All rights reserved.
Not applicable